Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Titel:
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Auteur:
Qin, Shukui Li, Qiu Gu, Shanzhi Chen, Xiaoming Lin, Lizhu Wang, Zishu Xu, Aibing Chen, Xi Zhou, Cuncai Ren, Zhenggang Yang, Lin Xu, Li Bai, Yuxian Chen, Lei Li, Jun Pan, Hongming Cao, Bangwei Fang, Weijia Wu, Wei Wang, Ge Cheng, Ying Yu, Zhuang Zhu, Xu Jiang, Da Lu, Yinying Wang, Huaming Xu, Jianming Bai, Li Liu, Yunpeng Lin, Hailan Wu, Changping Zhang, Yang Yan, Ping Jin, Chunlei Zou, Jianjun